CDC recommends Pfizer or Moderna booster after J&J vaccine
Adults who received an initial J&J COVID-19 vaccine should receive a Pfizer or Moderna booster at least two months later for the best protection, according to a study released yesterday by the Centers for Disease Control and Prevention. The study examined 80,287 emergency department/urgent care visits and 25,244 hospitalizations in 10 states between Dec. 16, 2021, and March 7, 2022, when omicron was the predominant variant, and found adults who received a Pfizer or Moderna booster after the J&J vaccine were better protected than those who received one or two J&J doses.
Related News Articles
Headline
The Department of Health and Human Services June 30 announced it will terminate emergency use authorization declarations for certain drugs and medical devices…
Headline
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention…